Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
95.95
+0.26 (0.27%)
Nov 18, 2026, 4:00 PM EST - Market closed
PBE Holdings Information
PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Regeneron Pharmaceuticals stock at 5.88%, Biogen at 5.87%, Gilead Sciences at 5.80%, Royalty Pharma at 5.68%, and Amgen at 5.38%.
Total Holdings
33
Top 10 Percentage
50.11%
Asset Class
Equity
ETF Category
Health
Assets
425.03M
PE Ratio
26.87
Breakdown by Country
Top 25 Holdings
Updated Nov 16, 2026